Revvity Diltiazem, Cis-(+)--, 1mci (37mbq)

Revvity 1mCi quantities of Diltiazem, cis-(+)-[N-Methyl-³H]-, are available for your research. Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used to treat hypertension and arrythmia. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (B_max), dissociation constants (K_d), association and dissociation rates (k_on and k_off), and inhibitor constants (K_i) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity References for NET847: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Rupniak, N.M.J., Boyce, S., Williams, A.R., Cook, g., Longmore, J., Seabrook, g.R., Caeser, M., Iversen, S.D. and Hill, R.g. (1993), Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. British Journal of Pharmacology, 110: 1607–1613.Hans Schoemaker, Polyamines allosterically modulate [3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain, In European Journal of Pharmacology: Molecular Pharmacology, Volume 225, Issue 2, 1992, Pages 167-169.